Several new studies were published earlier this month describing the sequencing of over 2,600 cancer genomes. What the results show include what sorts of mutations drive cancer development and how evolution makes cancers so difficult to treat.
A miracle cancer prevention and treatment? Not necessarily as the analysis of 26 articles by legendary Hans Eysenck shows.
A recent investigation at King's College London has revealed major problems in the scientific career of one of psychology's most published scientists, Hans Eysenck.
The narrative we hear from the media (and, of course, from alternative medicine mavens) is that we are "losing the war on cancer." It's actually not true. As the latest statistics from the American Cancer Society show, the mortality rate from cancer has been declining for decades.
Do dietary supplements offer advantages or risks to breast cancer patients undergoing chemotherapy?
Chris Wark has a new book out, with the unsurprising title of Chris Beat Cancer. It purports to be a guide to beating cancer. It's not.
Drug approval is a process that should be and, for the most part, is rooted in rigorous science. However, there is always a countervailing pressure to approve new drugs rapidly, particularly in cancer. That's why the FDA created the accelerated approval program in the early 1990s. Unfortunately, increasingly this approval process appears to be failing us in oncology. Reform is needed.